Wook Kim
Finanzdirektor/CFO bei HLB GLOBAL CO., LTD.
Aktive Positionen von Wook Kim
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HLB CO., LTD. | Direktor/Vorstandsmitglied | - | - |
| HLB GLOBAL CO., LTD. | Direktor/Vorstandsmitglied | 01.08.2018 | - |
| Finanzdirektor/CFO | 01.08.2018 | - |
Karriereverlauf von Wook Kim
Ehemalige bekannte Positionen von Wook Kim
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Direktor/Vorstandsmitglied | 01.01.2019 | - |
Ausbildung von Wook Kim
| Korea University | Undergraduate Degree |
Statistik
International
| Südkorea | 4 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 3 |
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Energy Minerals | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HLB CO., LTD. | Health Technology |
| HLB GLOBAL CO., LTD. | Energy Minerals |
| Private Unternehmen | 1 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
